Indofarma Tbk. vs Indo Straits Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Indo Straits Tbk. trades at Rp260 (market cap 144.14B, 66.9K 24h volume). The key difference: Indofarma Tbk. is far larger — about 2.7× Indo Straits Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | PTIS | |
|---|---|---|
Market Cap | 390.51B | 144.14B |
Volume | — | 66.9K |
Lot | — | 669 |
Turnover | — | 17.5M |
Average Price | — | 261.64 |
Value | — | 17.5M |
Indicative Equilibrium Price | — | 260 |
Indicative Equilibrium Volume | — | 20 |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT Indo Straits (the "Company") was established based on Notarial Deed No 319 of Ridwan SH, dated January 21, 1985. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 4 of Leolin Jayanti SH dated March 8, 2011 pertaining of change composition of the Company's board of Commissioners and Boards of Directors, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity.
Read more on PTIS →